Cargando…

Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling

The poly(ADP-ribose) polymerase (PARP) Tankyrase (TNKS and TNKS2) is paramount to Wnt-β-catenin signaling and a promising therapeutic target in Wnt-dependent cancers. The pool of active β-catenin is normally limited by destruction complexes, whose assembly depends on the polymeric master scaffolding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mariotti, Laura, Templeton, Catherine M., Ranes, Michael, Paracuellos, Patricia, Cronin, Nora, Beuron, Fabienne, Morris, Edward, Guettler, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980433/ https://www.ncbi.nlm.nih.gov/pubmed/27494558 http://dx.doi.org/10.1016/j.molcel.2016.06.019

Ejemplares similares

Structural basis of tankyrase activation by polymerization
por: Pillay, Nisha, et al.
Publicado: (2022)

Regulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding
por: Mariotti, Laura, et al.
Publicado: (2017)

Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach
por: Pollock, Katie, et al.
Publicado: (2017)

Solution NMR assignment of the ARC4 domain of human tankyrase 2
por: Zaleska, Mariola, et al.
Publicado: (2019)

WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling
por: James, Richard G., et al.
Publicado: (2012)

Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase
por: Pollock, Katie, et al.
Publicado: (2019)

Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation
por: Ranes, Michael, et al.
Publicado: (2021)

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
por: Ma, Li, et al.
Publicado: (2015)

Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/β-Catenin Signaling
por: Yang, Hong-Yi, et al.
Publicado: (2019)

Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening
por: Li, Bo, et al.
Publicado: (2020)

Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta
por: Martino-Echarri, Estefania, et al.
Publicado: (2016)

The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain
por: Sowa, Sven T., et al.
Publicado: (2022)

USP25 regulates Wnt signaling by controlling the stability of tankyrases
por: Xu, Daichao, et al.
Publicado: (2017)

Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity
por: Pedersen, Nina Marie, et al.
Publicado: (2016)

Ubiquitin Ligase RNF146 Regulates Tankyrase and Axin to Promote Wnt Signaling
por: Callow, Marinella G., et al.
Publicado: (2011)

XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
por: Tian, Xiao-Hong, et al.
Publicado: (2013)

Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase
por: Xu, Wenshu, et al.
Publicado: (2017)

Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development
por: Chiang, Y. Jeffrey, et al.
Publicado: (2008)

Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
por: Bao, Renyue, et al.
Publicado: (2012)

Structural Basis and Selectivity of Tankyrase Inhibition by a Wnt Signaling Inhibitor WIKI4
por: Haikarainen, Teemu, et al.
Publicado: (2013)

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer
por: Mashima, Tetsuo, et al.
Publicado: (2017)

FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases
por: Gustafson, Carl T., et al.
Publicado: (2017)

Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2
por: Qiu, Wei, et al.
Publicado: (2014)

Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase—A Potential Strategy for Suppression of the Wnt Pathway
por: Roy, Sujayita, et al.
Publicado: (2015)

Novel insight into the function of tankyrase
por: Kim, Mi Kyung
Publicado: (2018)

Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation
por: Bhardwaj, Amit, et al.
Publicado: (2017)

Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer
por: Yang, Jiao, et al.
Publicado: (2019)

Tankyrases/β-catenin Signaling Pathway as an Anti-proliferation and Anti-metastatic Target in Hepatocarcinoma Cell Lines
por: Huang, Jianghai, et al.
Publicado: (2020)

Origin Licensing Requires ATP Binding and Hydrolysis by the MCM Replicative Helicase
por: Coster, Gideon, et al.
Publicado: (2014)

The N-Terminal Part of the Dishevelled DEP Domain Is Required for Wnt/β-Catenin Signaling in Mammalian Cells
por: Paclíková, Petra, et al.
Publicado: (2017)

Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and β-Catenin Degradation
por: Thorvaldsen, Tor Espen, et al.
Publicado: (2017)

Tankyrase Regulates Neurite Outgrowth through Poly(ADP-ribosyl)ation-Dependent Activation of β-Catenin Signaling
por: Mashimo, Masato, et al.
Publicado: (2022)

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance
por: Quackenbush, Kevin S., et al.
Publicado: (2016)

A SAM-key domain required for enzymatic activity of the Fun30 nucleosome remodeler
por: Karl, Leonhard A, et al.
Publicado: (2023)

Wnt/β-catenin signaling is required for development of the exocrine pancreas
por: Wells, James M, et al.
Publicado: (2007)

Centrosomes are required for proper β-catenin processing and Wnt response
por: Vora, Setu M., et al.
Publicado: (2020)

The telomeric PARP, tankyrases, as targets for cancer therapy
por: Seimiya, H
Publicado: (2006)

Evidence for tankyrases as antineoplastic targets in lung cancer
por: Busch, Alexander M, et al.
Publicado: (2013)

Tankyrases: Structure, Function and Therapeutic Implications in Cancer
por: Haikarainen, Teemu, et al.
Publicado: (2014)

Specific Eph receptor-cytoplasmic effector signaling mediated by SAM–SAM domain interactions
por: Wang, Yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kbuvpd4nb27tnvkokpq41q96pg